Evidence map›Paper›PMID 39997217›Full record

ArticleNucleic acids research2025

Phosphorylated BLM peptide acts as an agonist for DNA damage response.

Ritu Agrawal, Himanshi Agarwal, Chetana Mukherjee, Baishali Chakraborty, Vandana Sharma, Vivek Tripathi, Nitin Kumar, Swati Priya, Nidhi Gupta, Gagan Deep Jhingan and 2 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ritu AgrawalBiotechnology Research and Innovation Council-National Institute of Immunology (BRIC-NII), Aruna Asaf Ali Marg, New Delhi110067, India.
Himanshi AgarwalBiotechnology Research and Innovation Council-National Institute of Immunology (BRIC-NII), Aruna Asaf Ali Marg, New Delhi110067, India.
Chetana MukherjeeBiotechnology Research and Innovation Council-National Institute of Immunology (BRIC-NII), Aruna Asaf Ali Marg, New Delhi110067, India.
Baishali ChakrabortyBiotechnology Research and Innovation Council-National Institute of Immunology (BRIC-NII), Aruna Asaf Ali Marg, New Delhi110067, India.
Vandana SharmaBiotechnology Research and Innovation Council-National Institute of Immunology (BRIC-NII), Aruna Asaf Ali Marg, New Delhi110067, India.
Vivek TripathiBiotechnology Research and Innovation Council-National Institute of Immunology (BRIC-NII), Aruna Asaf Ali Marg, New Delhi110067, India.
Nitin KumarBiotechnology Research and Innovation Council-National Institute of Immunology (BRIC-NII), Aruna Asaf Ali Marg, New Delhi110067, India.
Swati PriyaBiotechnology Research and Innovation Council-National Institute of Immunology (BRIC-NII), Aruna Asaf Ali Marg, New Delhi110067, India.
Nidhi GuptaRegional Centre for Biotechnology, Faridabad 121001, Haryana, India.
Gagan Deep JhinganValerian Chem Pvt. Ltd, Vproteomics, Green Park, Delhi 110016, India.
Avinash BajajRegional Centre for Biotechnology, Faridabad 121001, Haryana, India.
Sagar SenguptaBiotechnology Research and Innovation Council-National Institute of Immunology (BRIC-NII), Aruna Asaf Ali Marg, New Delhi110067, India.ORCID 0000-0002-6365-1770

Funding

Anusandhan National Research Foundation (ANRF), India JBR/2023/000020Board of Research in Nuclear Sciences 58/14/17/2021-BRNSCouncil of Scientific and Industrial Research, India 27/0387/23/EMR-IIDepartment of Biotechnology, Ministry of Science and Technology, India BT/PR41739/BRB/10/1974/2021Indo-French Centre for the Promotion of Advanced Research IFC/6803-1/2022National Institute of Biomedical GenomicsNational Institute of ImmunologyScience and Engineering Research Board CRG/2020/000125
6 · The paper itself

Abstract

Upon exposure to ionizing irradiation, the MRE11-RAD50-NBS1 complex potentiates the recruitment of ATM (ataxia-telangiectasia mutated) kinase to the double-strand breaks. We show that the lack of BLM causes a decrease in the autophosphorylation of ATM in mice mammary glands, which have lost one or both copies of BLM. In isogenic human cells, the DNA damage response (DDR) pathway was dampened in the absence of BLM, which negatively affected the recruitment of DDR factors onto the chromatin, thereby indicating a direct role of BLM in augmenting DDR. Mechanistically, this was due to the BLM-dependent dissociation of inactive ATM dimers into active monomers. Fragmentation analysis of BLM followed by kinase assays revealed a 20-mer BLM peptide (91-110 aa), sufficient to enhance ATM-dependent p53 phosphorylation. ATM-mediated phosphorylation of BLM at Thr99 within BLM (91-110) peptide enhanced ATM kinase activity due to its interaction with NBS1 and causing ATM monomerization. Delivery of phosphomimetic T99E counterpart of BLM (91-110 aa) peptide led to ATM activation followed by restoration of the DDR even in the absence of ionizing irradiation (both in cells and in BLM knockout mice), indicating its role as a DDR agonist, which can be potentially used to prevent the initiation of neoplastic transformation.

Indexed as

DNA DamageRecQ HelicasesAnimalsAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell LineDNA-Binding ProteinsDNA RepairFemaleHumansMiceMice, KnockoutNuclear ProteinsPeptidesPhosphorylationProtein Serine-Threonine KinasesAtaxia Telangiectasia Mutated ProteinsATM protein, humanAtm protein, mouseBloom syndrome proteinCell Cycle ProteinsDNA-Binding ProteinsNBN protein, humanNuclear ProteinsPeptidesProtein Serine-Threonine KinasesRecQ HelicasesTumor Suppressor Protein p53Tumor Suppressor Proteins

Identifiers

PMID39997217
PMCPMC11851105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.